Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Valves01:16

Heart Valves

7.1K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
7.1K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

73
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
73
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

84
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
84
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

46
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
46
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

72
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
72

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Outcomes of Dedicated Leaflet Modification for Bioprosthetic Valve-In-Valve TAVR: A 150-Patient Commercial Experience.

JACC. Cardiovascular interventions·2026
Same author

EEG findings in SERAC1-related MEGD(H)EL syndrome.

Epileptic disorders : international epilepsy journal with videotape·2026
Same author

Sternal precautions in high-risk cardiac surgery patients: Impact of a novel movement strategy and a wearable external sternal support device.

JTCVS open·2026
Same author

Aging and the global cancer burden: A population-based cohort study and predictive modelling analysis using the global cancer database.

Journal of cancer research and therapeutics·2026
Same author

Outcomes of Mitral Transcatheter Edge-to-Edge Repair in Patients With Small Mitral Valve Area.

Structural heart : the journal of the Heart Team·2026
Same author

Early outcomes of facilitated transfemoral versus alternative access for transcatheter aortic valve replacement in patients with peripheral arterial disease.

The Journal of invasive cardiology·2026

Related Experiment Video

Updated: Oct 18, 2025

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.0K

Current and future transcatheter aortic valve replacement valves.

Rachel Eikelboom1, Ricky Muller Moran1, Weiang Yan1

  • 1St. Boniface Hospital, University of Manitoba, WInnipeg, Manitoba, Canada.

Current Opinion in Cardiology
|October 1, 2021
PubMed
Summary
This summary is machine-generated.

This review compares current and investigational transcatheter aortic valve replacement (TAVR) devices, focusing on Edwards SAPIEN S3 and Medtronic Evolut PRO+. Further advancements are needed for expanded TAVR indications and improved valve durability.

More Related Videos

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
11:12

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Published on: October 17, 2013

14.0K
Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

254

Related Experiment Videos

Last Updated: Oct 18, 2025

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.0K
Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
11:12

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Published on: October 17, 2013

14.0K
Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

254

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Aortic stenosis management has been revolutionized by transcatheter aortic valve replacement (TAVR).
  • Continuous innovation in TAVR valve technology is essential for expanding clinical applications.
  • The development of more durable and safer prosthetic valves remains a key objective.

Purpose of the Study:

  • To review and compare currently available commercial TAVR valves.
  • To analyze investigational and preclinical TAVR valves.
  • To highlight the design features and clinical outcomes of Edwards SAPIEN S3 and Medtronic Evolut PRO+.

Main Methods:

  • Systematic review of randomized and nonrandomized trials.
  • Comparative analysis of TAVR valve designs and clinical data.
  • Evaluation of clinical evidence for specific TAVR devices.

Main Results:

  • Detailed comparison of Edwards SAPIEN S3 and Medtronic Evolut PRO+.
  • Summary of clinical outcomes for commercial and investigational TAVR valves.
  • Identification of clinical scenarios favoring specific TAVR devices.

Conclusions:

  • TAVR technology has significantly advanced aortic stenosis treatment.
  • Ongoing research and development are crucial for future TAVR improvements.
  • Enhanced valve durability and expanded indications are key future goals for TAVR.